School of Medicine
Showing 1-20 of 23 Results
-
Kristin Sainani (n e Cobb)
Professor (Teaching) of Epidemiology and Population Health
Current Research and Scholarly InterestsScience writing, science communication, biostatistics. Research areas: osteoporosis, stress fractures, sports injuries, female athlete triad.
-
Lee M. Sanders, MD, MPH
Professor of Pediatrics (General Pediatrics), of Health Policy and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsI conduct interdisciplinary research to understand literacy as potentially modifiable lens for addressing maternal and child health disparities from birth through early adulthood. Applying mixed methods approaches (health-services, epidemiology, ethnography), I have been principal investigator on extramurally-funded research projects (NIH, PCORI, FDA) that aim to examine "natural experiments" in policy and/or to design, implement and test novel system-level interventions.
-
Gary M. Shaw
NICU Nurses Professor and Professor (Research), by courtesy, of Epidemiology and Population Health and of Obstetrics and Gynecology (Maternal Fetal Medicine)
Current Research and Scholarly InterestsPrimary research interests include 1) epidemiology of birth defects, 2) gene-environment approaches to perinatal outcomes, and 3) nutrition and reproductive outcomes.
-
Clifford Charles Sheckter
Assistant Professor of Surgery (Plastic and Reconstructive Surgery)
Masters Student in Health Policy, admitted Autumn 2022BioDr. Cliff Sheckter is a California native, growing up in the Eastern Sierra. He graduated from UCLA with a BS in Anthropology and earned summa cum laude and Phi Beta Kappa honors. He attended USC (Keck) for medical school on an academic scholarship and graduated valedictorian with Alpha Omega Alpha honors. He fell in love with burn care while at LAC+USC and matriculated into the Stanford Plastic & Reconstructive Surgery Residency in 2013. While in residency, he pursued a fellowship in Health Systems Design at Stanford’s Clinical Excellence Research Center, which ignited his interest in health services research. During residency, Dr. Sheckter investigated health systems outcomes in burn care and reconstructive surgery. He pursued additional training in Surgical Critical Care at the University of Washington with a focus on integrated, complex burn care. There he investigated quality of life outcomes in burn survivors with a particular focus in financial toxicity.
Dr. Sheckter’s current research involves improving the quality of life for burn survivors and investigating the relationship between healthcare financial structures and the value of healthcare delivery. He currently holds an NIH KL-2 career development award to investigate the effects of private equity investing into ambulatory surgery within the US. In addition, he is the Ryan-Upson Scholar in Plastic & Reconstructive Surgery with active investigations in health equity within surgery.
Dr. Sheckter is one of a few surgeons double-board certified in Surgical Critical Care and Plastic Surgery. He practices critical care medicine as an intensivist in the Stanford Surgical ICU. He is the Director of the Regional Burn Center at Santa Clara Valley Medical Center where he cares for critically injured burn patients. He also performs scar reconstruction using surgical and laser techniques. -
Julia Fridman Simard
Associate Professor of Epidemiology and Population Health, of Medicine (Immunology & Rheumatology) and, by courtesy, of Obstetrics and Gynecology (Maternal Fetal Medicine)
BioJulia Fridman Simard, ScD, is an Associate Professor of Epidemiology & Population Health, and, by courtesy, of Medicine in Immunology and Rheumatology and Obstetrics and Gynecology in Maternal Fetal Medicine at Stanford University School of Medicine.
Dr. Simard earned her Masters and Doctorate of Science in Epidemiology degrees at the Harvard School of Public Health. During that time she trained with investigators at the Section of Clinical Sciences, Division of Rheumatology, Immunology, and Allergy at Brigham and Women’s Hospital and the Cardiovascular Epidemiology Research Unit at Beth Israel Deaconess Medical Center. In 2008, Dr. Simard relocated to Sweden to begin a Postdoctoral Fellowship in Clinical Epidemiology at the Karolinska Institutet in Stockholm. She became an Assistant Professor in their Clinical Epidemiology Unit in 2011, and was later honored with a Karolinska Institutet Teaching Award. Leveraging the population-based registers of Sweden, Dr. Simard initiated a national register linkage study to examine the utility of registers in Systemic Lupus Erythematosus (SLE) research and develop an extensive data repository for future epidemiologic investigations.
While maintaining a close collaboration with the Karolinska Institutet, she joined Stanford’s Epidemiology faculty in 2013. Dr. Simard studies outcomes such as malignancy, stroke, infection, and mortality, in patients with systemic autoimmune rheumatic diseases with a focus on systemic lupus erythematosus. Recently her primary research focus has shifted to the intersection between reproductive epidemiology and rheumatic disease fueled by a K01 career development award from the NIH (NIAMS) to study maternal and fetal outcomes in systemic lupus pregnancy. This led to collaborations with colleagues at Stanford, throughout the US, and abroad, and a series of projects focused on the diagnosis of preeclampsia and associated risks in pregnant women with systemic lupus. Dr. Simard was awarded a Peter Joseph Pappas Research Grant from the Preeclampsia Foundation for her lab's work examining preeclampsia risk in high-risk populations, and a McCormick Faculty Award from Stanford Medicine to take important steps towards disentangling preeclampsia from lupus nephritis. Dr. Simard is leading an international study of hydroxychloroquine in lupus pregnancy leveraging mixed methods in partnership with qualitative researchers, patients, clinicians, and epidemiologists in Sweden, Canada, and in the United States.
In addition to these issues of misclassification in reproductive rheumatology questions, Dr. Simard's lab is also interested in how misclassification, missed opportunities, and misdiagnosis contribute to disparities in complex conditions such as systemic lupus. In addition to methodologic issues around misclassification and bias and the largely clinical epidemiology focus of her work, Dr. Simard's work examines social determinants of health and health disparities. Dr. Simard was recently awarded an R01 from NIH (NIAID) to study the role of cognitive and unconscious bias in clinical decision making for female-predominant diseases including lupus. -
Shamsi Soltani
Ph.D. Student in Epidemiology and Clinical Research, admitted Autumn 2021
BioShamsi Soltani is doctoral student in the Department of Epidemiology and Population Health and a trainee with the Center for Population Health Sciences, both in the Stanford School of Medicine. She is also a fellow in the Training in Advanced Data Analytics for Behavioral and Social Sciences (TADA-BSSR) program, supervised by Drs. Abby King and Lorene Nelson.
-
Sahana Somasegar MD
Masters Student in Epidemiology and Clinical Research, admitted Autumn 2022
Fellow in MedicineBioSahana Somasegar, MD, graduated from Cornell University in Human Biology, Health & Society, where she was a Presidential Research Scholar and studied endothelial cell migration, invasion, and growth to further understand angiogenesis. Sahana then attended Case Western Reserve University School of Medicine, where she led student organizations including the American Medical Women’s Association chapter and Oncology Interest group. While in medical school, Sahana received the Dean’s Summer Research Award and American Pediatric Society Fellowships. She ultimately graduated medical school in 2018 with Honors with Distinction in Research. Sahana subsequently completed her Obstetrics and Gynecology residency at the University of Chicago, where she served as Administrative Chief Resident in her final year. She also received the Society of Gynecologic Oncology Outstanding Resident in Gynecologic Oncology Award and the Golden Apple Medical Student Teaching Award. During residency, she was involved in several research efforts, including research focused on clinical outcomes in gynecologic cancers after targeted treatments based on somatic mutations, which was published as Editor’s Choice in Gynecologic Oncology. Her research contributions have been published in Gynecologic Oncology, Journal of Clinical Oncology: Oncology Practice, International Journal of Gynecological Pathology, Gynecologic Oncology Reports, and others. After completing residency, Sahana joined Stanford University for fellowship in Gynecologic Oncology. She is currently pursuing a Masters in Epidemiology and Clinical Research, with the hope of continuing to conduct clinical research and participate in clinical trials throughout her career. Under the guidance of Dr. Marcia Stefanick and Dr. Allison Kurian, her thesis is focused on geographical differences in risk factors, work-up and diagnosis, and survival in uterine cancer to better understand how to target public health interventions to combat disparities. She is also working on clinical projects related to surgical techniques and large-database analysis of trends in gynecologic cancer survival.
-
Marcia L. Stefanick, Ph.D.
Professor (Research) of Medicine (Stanford Prevention Research Center), of Obstetrics and Gynecology and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsMarcia L. Stefanick, Ph.D is a Professor of Medicine Professor of Obstetrics and Gynecology, and by courtesy, Professor of Epidemiology and Population Health at Stanford University School of Medicine. Dr. Stefanick’s research focuses on chronic disease prevention (particularly, heart disease, breast cancer, osteoporosis, and dementia) in both women and men. She is currently the Principal Investigator the Women’s Health Initiative (WHI) Extension Study, having been the PI of the Stanford Clinical Center of the landmark WHI Clinical Trials and Observational Study since 1994 and Chair of the WHI Steering and Executive Committees from 1998-2011, as well as PI of the WHI Strong and Healthy (WHISH) Trial which is testing the hypothesis that a DHHS-based physical activity intervention, being delivered to a multi-ethnic cohort of about 24,000 WHI participants across the U.S., aged 68-99 when the trial started in 2015, will reduce major cardiovascular events over 8 years, compared to an equal number of “usual activity” controls. Dr. Stefanick is also PI of the Osteoporotic Study of Men (MrOS) which is continuing to conduct clinical assessments of bone and body composition in survivors of an original cohort of nearly 6000 men aged 65 and over in 2001. As founding Director of the Stanford Women’s Health and Sex Differences in Medicine (WHSDM, “wisdom”) Center, she plays a major role in promoting research and teaching on Sex and Gender in Human Physiology and Disease, Women’s Health and Queer Health and Medicine. Dr. Stefanick also plays major leadership roles at the Stanford School of Medicine, including as co-leader of the Population Sciences Program of the Stanford Cancer Institute, Stanford’s NCI-funded comprehensive cancer center.
Dr. Stefanick obtained her B.A. in biology from the University of Pennsylvania, Philadelphia, PA (1974), then pursued her interest in hormone and sex difference research at the Oregon Regional Primate Research Center, after which she obtained her PhD in Physiology at Stanford University, focusing on reproductive physiology and neuroendocrinology, with exercise physiology as a secondary focus. Her commitment to human research led to a post-doctoral fellowship in Cardiovascular Disease Prevention at the Stanford Prevention Research Center, which has been her academic home for nearly 40 years.
